4.8 Review

Development of individualized anti-metastasis strategies by engineering nanomedicines

Journal

CHEMICAL SOCIETY REVIEWS
Volume 44, Issue 17, Pages 6258-6286

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c4cs00511b

Keywords

-

Funding

  1. National Nature Science Foundation of China [51102259, 31271021, 31222023]
  2. Distinguished Young Scholars of Sichuan University [2011SCU04B18]
  3. Intramural Research Program, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health

Ask authors/readers for more resources

Metastasis is deadly and also tough to treat as it is much more complicated than the primary tumour. Anti-metastasis approaches available so far are far from being optimal. A variety of nanomedicine formulae provide a plethora of opportunities for developing new strategies and means for tackling metastasis. It should be noted that individualized anti-metastatic nanomedicines are different from common anti-cancer nanomedicines as they specifically target different populations of malignant cells. This review briefly introduces the features of the metastatic cascade, and proposes a series of nanomedicine-based anti-metastasis strategies aiming to block each metastatic step. Moreover, we also concisely introduce the advantages of several promising nanoparticle platforms and their potential for constructing state-of-the-art individualized anti-metastatic nanomedicines.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available